 ST. LOUIS, July 26, 2021 GLOBE NEWSWIRE -- Stereotaxis NYSE: STXS, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Myriam J. Curet, M.D., to its Board of Directors. 